# Aquestive (AQST) — News

AQST · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/aqst/news

## Recent headlines

- [FDA sets Aquestive's anaphylm PDUFA date for March 16, 2027](https://www.ainvest.com/news/fda-sets-aquestive-anaphylm-pdufa-date-march-16-2027-2610) — AInvest Wire, Oct 15, 2026
- [Aquestive Therapeutics - PDUFA goal action date for anaphylm set for March 16, 2027](https://www.ainvest.com/news/aquestive-therapeutics-pdufa-goal-action-date-anaphylm-set-march-16-2027-2610) — AInvest Wire, Oct 15, 2026
- [Aquestive Therapeutics - Canadian new drug submission for anaphylm planned for Q4 2026](https://www.ainvest.com/news/aquestive-therapeutics-canadian-drug-submission-anaphylm-planned-q4-2026-2610) — AInvest Wire, Oct 15, 2026
- [Eton Pharmaceuticals - To pay aQuestive royalties at mid-teens percentage rate on Libervant sales - SEC filing](https://www.ainvest.com/news/eton-pharmaceuticals-pay-aquestive-royalties-mid-teens-percentage-rate-libervant-sales-sec-filing-2610) — AInvest Wire, Oct 14, 2026
  Eton Pharmaceuticals has agreed to pay Aquestive Therapeutics royalties at a mid-teens percentage rate on future sales of Libervant, according to a recent SEC filing. The details of the agreement were disclosed in a regulatory submission, which outlines the financial terms of the partnership .…
- [Eton Pharmaceuticals - To pay Aquestive up to $47.50 mln in milestone payments - SEC filing](https://www.ainvest.com/news/eton-pharmaceuticals-pay-aquestive-47-50-mln-milestone-payments-sec-filing-2610) — AInvest Wire, Oct 14, 2026
  Eton Pharmaceuticals has agreed to pay Aquestive Therapeutics, Inc. up to $47.5 million in milestone payments, according to a recent SEC filing . The terms of the agreement outline specific financial obligations tied to the achievement of development and regulatory milestones related to one of…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).